Stories from The University of Texas Health Science Center at Houston (UTHealth)
April 15, 2021
A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson's disease has been launched at The University of Texas Health Science Center at Houston (UTHealth).
April 15, 2021
A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).
April 8, 2021
The John S. Dunn Foundation has made a transformative $25 million commitment to The University of Texas Health Science Center at Houston (UTHealth) to bolster the university’s behavioral health initiatives and address significant gaps in mental health care services in our communities.
April 8, 2021
The University of Texas Health Science Center at Houston (UTHealth) publicly launched its first comprehensive campaign Many Faces. One Mission. on Thursday, April 8. The campaign, representing the largest philanthropic effort in UTHealth’s history, aims to raise $500 million to address pressing health challenges and secure the institution’s future as a top health science center. Since the campaign’s quiet phase began in 2015, UTHealth’s closest friends have given more than $400 million in gifts and pledges.
April 1, 2021
A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.
March 31, 2021
Researchers are using a novel health platform that links them to shared electronic health records from consented patients to track long-term effects of COVID-19 in a new study by UTHealth.
March 30, 2021
A string of opioid trade sites on the dark web have been uncovered by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics.
March 17, 2021
Stroke patients received clot-busting medications such as tissue plasminogen activator (tPA) faster, more often, and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to researchers with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center (TMC).
March 15, 2021
Researchers with The University of Texas Health Science Center at Houston (UTHealth) have created an acronym, RAPIDO ©, to move forward much-needed efforts to address stroke sign and symptom awareness among at-risk Spanish-speaking individuals.
March 15, 2021
Four months after launching the nation’s largest COVID-19 serological testing assessment, Texas CARES, researchers at The University of Texas Health Science Center at Houston (UTHealth) and the Texas Department of State Health Services (DSHS) have compiled preliminary data estimating that 14% to 24% of Texans have COVID-19 antibodies.
Use the form below to perform a new search.